Epidemiology International Journal (EIJ)

ISSN: 2639-2038

Review Article

Mesenchymal Stem Cells Therapy for Muscular Atrophy and Sarcopenia

Authors: Ma H and Yang J*

DOI: 10.23880/eij-16000231

Abstract

Sarcopenia is characterized by a loss of skeletal muscle mass, strength and function, and badly influence health and quality of the patients, the prevalence of sarcopenia is increasing particularly in the people aged 65 years or above, and the phenomena of chronic-inflammation and inflamm-aging is a major reason to multitude of geriatric conditions including sarcopenia. With the rapid development of regenerative medicine, Mesenchymal stem cells therapy showed a potential possibility to treat or alleviate the symptoms of muscular atrophy and sarcopenia. Here, we will summarize the recent progress of Mesenchymal stem cells therapy on muscular Atrophy and sarcopenia, which may provide some ideas for aging-related or degenerative diseases treatment.

Keywords: Muscular Atrophy and Arcopenia; Regeneration; Treatment; MSCs

View PDF

F1 europub scilit.net

Chat with us on WhatsApp

Welcome to Medwin Publishers. How can we help you today?